Rivernorth Capital Management’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Rivernorth Capital Management’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-50,000	Closed	-$503K	–	790
2022 Q4	$503K	Hold	50,000	–	–	0.02%	392
2022 Q3	$495K	Hold	50,000	–	–	0.02%	480
2022 Q2	$490K	Hold	50,000	–	–	0.02%	468
2022 Q1	$489K	Hold	50,000	–	–	0.02%	476
2021 Q4	$486K	Hold	50,000	–	–	0.02%	413
2021 Q3	$488K	Hold	50,000	–	–	0.03%	323
2021 Q2	$483K	Buy	+50,000	New	+$489K	0.03%	309

Rivernorth Capital Management's MSAC Position: Q1 2023 in Review

Rivernorth Capital Management sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 50,000 shares — an estimated $503K sold.

Rivernorth Capital Management first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $503K in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Rivernorth Capital Management reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Rivernorth Capital Management sold 50,000 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $503K.
Rivernorth Capital Management first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 7 quarters.
Rivernorth Capital Management's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $503K in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Rivernorth Capital Management's 13F filing for Q1 2023, filed 15 May 2023.